Introduction
Functionally differentiated mammary gland consists of secretory alveoli organized into lobules and connected by branching ducts leading to the surface of the body. The most important portion of the mammary development occurs postnatally. Only a few ducts are formed late in embryonic development, and at birth, the mammary gland remains rudimentary. Intensive growth and branching morphogenesis take place during sexual maturation leading to the establishment of the mammary ductal system. The secretory tissues, the mammary alveoli, develop during pregnancy. The gland attains its fully differentiated state at lactation.
The mammary epithelium is composed of two cell layers, the luminal and basal myoepithelial. During lactation, luminal cells produce and secrete milk, whereas basal myoepithelial cells contract to eject the milk from the body. Mammary morphogenesis and differentiation are controlled by systemic hormones, soluble growth factors, cell-cell and cell-ECM interactions. In the mammary epithelium, hormonal receptors essential for gland development and homeostasis, such as estrogen receptor-a (ERa), progesterone receptor (PR) and prolactin receptor, are expressed mostly by luminal cells rather than basal myoepithelial cells (Brisken and O'Malley 2010) . However, as discussed below, myoepithelial cells in the mammary tissue respond to hormonal stimulation in vivo. In addition, these cells express various receptors for soluble and cell surface-associated signaling molecules. They also produce most of the basement membrane components and are involved in permanent reciprocal interactions with the connective tissue surrounding the mammary epithelium.
The myoepithelium is organized differently in the ducts and alveoli. Ductal myoepithelial cells are arranged in a more or less continuous monolayer, whereas alveolar myoepithelial cells are stellate-shaped and do not form a continuous layer between the secretory epithelium and the surrounding basement membrane (Fig. 1) .
Differentiated myoepithelial cells are contractile cells with an ultrastructure reminiscent of smooth muscle. Myoepithelial cells contain large amounts of microfilaments and dense plaques and express smooth muscle-specific cytoskeletal and contractile proteins. Myoepithelial cells form desmosomes and hemidesmosomes, and they are separated from the connective tissue by the basement membrane, a special type of ECM. However, it should be borne in mind that, unlike smooth muscle cells, which originate from mesodermal precursors and neural crest cells, mammary myoepithelial cells and luminal cells are derived from the ectoderm. In addition to displaying phenotypic features of smooth muscle cells, myoepithelial cells have all the characteristics of basal cells from stratified epithelia. In particular, they express basal-type cytokeratins 5, 14 (K5 and K14, respectively) and cytokeratin 17, P-cadherin and high levels of DNp63.
Two discoveries reported a few years ago suggested that mammary basal epithelial cells might play a key role in normal mammary development and tumorigenesis. First, the transcriptional profiling of mammary carcinomas revealed a subset of tumors expressing basal cell markers and characterized by a particularly poor clinical outcome (Gusterson 2009; Foulkes et al., 2011 and references therein) . Second, several reports describing the isolation and partial characterization of stem/progenitor cells from adult mouse mammary gland and mammary epithelial cell lines indicated that these cells might reside in the basal compartment of the mammary epithelium (Deugnier et al., 2006; Shackleton et al., 2006; Stingl et al., 2006; Sleeman et al., 2007) .
In this review, we focus essentially on the aspects of myoepithelial cell functional activity investigated by our team. We provide an overview of studies dealing with the control of myoepithelial cell differentiation, discuss the role of cell-cell and cell-ECM interactions involving basal myoepithelial cells in mammary gland development and, finally, summarize current knowledge concerning the contribution of basal myoepithelial cells to the regenerative potential of the mammary epithelium and tumorigenesis. An important physiological property of myoepithelial cells, their tumor-suppressor potential, has been discussed elsewhere (Barsky and Karlin 2006; Panday et al., 2011) . Here, we refer to the studies carried out in mouse, rat and human. Mammary gland development and pathology are clearly not identical in different mammalian species. Of note, the quiescent mammary gland of rodents consists of ramified ducts only, comprising small lateral or tertiary branches that give rise to alveoli in pregnancy, whereas adult human mammary gland, even in the absence of pregnancy, contains variable amounts of lobulo-alveoli (Anbazhagan et al., 1998; Naccarato et al., 2000) . Another notable difference between rodent and human mammary tissue concerns the stroma, the connective tissue surrounding the mammary epithelium. In mouse and rat, the stroma is fatty, rich in adipocytes, whereas human breast contains much more fibrous connective tissue. However, overall, the organization of the mammary parenchyma, at the cellular level, is similar in rodents and humans, and data obtained in rodent models provide essential information relevant to human breast development and disease.
Differentiation of mammary myoepithelial cells
The basal and luminal cells from the pseudostratified mammary epithelium are functionally and phenotypically distinct. Segregation of the two mammary epithelial compartments begins during embryonic development. In mammary buds from E15-mouse embryo, most, if not all, cells express basal cytokeratin K5, numerous cells stain positive for both, K5 and luminal cytokeratin 8 (K8), whereas expression of a basal cell marker p63 is already restricted to 2-3 basal cell layers (Fig. 2 A,B) . By E18, expression of K5, is higher in basal cells and lower in the cells concentrated in the future luminal part of the ducts, K8 displays the opposite pattern of expression, and p63 is restricted to the basal cell layer (Fig. 2 C,D) . Only few mammary basal cells from E18 mouse embryos express first smooth muscle-specific protein, a-smooth muscle actin (a-SMA (Fig. 2E) . In newborn mouse mammary glands, we have detected mammary basal epithelial cells positive for a-SMA and calponin, whereas another contractile protein, caldesmon, was absent from the neonatal mouse mammary epithelium and was detected in myoepithelial cells from three-week-old mice only ( Fig. 2F and data not shown). In rat embryo, at E15 and E18, basal epithelial cells from mammary rudiments stained negative for smooth muscle markers. a-SMA and smooth muscle-myosin were first detected in mammary epithelial basal cells from newborn rat females (Deugnier et al., 1995) . Thus, in rodents, basal cells from the embryonic mammary buds do not express smooth muscle markers, and myoepithelial cell differentiation begins during the perinatal period.
In human fetal breast, the first smooth muscle marker, a-SMA, was detected in basally located ductal cells after 22 to 23 weeks of gestation (Anbazhagan et al., 1998; Friedrichs et al., 2007) . At this developmental stage, luminal and basal cell layers could be clearly distinguished due to differences in expression of K8, the transcription factor AP2-a, the transcription factor AP2-g and HER1, the first two of these markers being restricted to luminal cells and the last two restricted to basal cells (Friedrichs et al., 2007) .
The differentiated phenotype, with the induction and upregulation of smooth muscle-specific contractile and cytoskeletal proteins, is acquired gradually by myoepithelial cells, essentially during postnatal mammary gland development. Changes in the adhesion system, including the integrin repertoire and the production of ECM components, accompany the maturation of mammary myoepithelial cells (Deugnier et al., 1995) .
In growing pubertal mouse mammary gland, the cap cells of the terminal end buds give rise to new ductal myoepithelial cells (Williams and Daniel 1983) . The terminal end buds are bulbous structures found at the growing tips of mammary ducts advancing into the fat pad, with the cap cells forming a monolayer at the front. The cap cells proliferate and, as the duct grows into the stroma, they progressively relocate to the underlying part of the duct, where they differentiate into myoepithelial cells (Williams and Daniel 1983) . Cap cells have a particular phenotype: they express a-SMA, P-cadherin and p63, but stain only weakly for basal-type cytokeratins K5 and K14. In addition, a recent study identified a specific marker of cap cells, s-SHIP, a protein of unknown biological 
B A
function structurally related to SHIP1, an SH2-containing inositol 5'-phosphatase (Bai and Rohrschneider 2010). The terminal end buds are present only in rapidly growing pubertal mammary glands, but cell populations similar to cap cells may exist at the extremities of all growing buds, at various developmental stages.
The smooth muscle marker expression of myoepithelial cells is not only regulated temporally during development, it is also regulated spatially. In adult quiescent human breast, a specific caldesmon variant implicated in the regulation of smooth muscle contraction is expressed by the myoepithelial cells of large ducts and galactophorous sinuses, but absent from intralobular small ducts and acini (Lazard et al., 1993) . Similarly, in the lactating rat mammary gland, ductal and alveolar myoepithelial cells differ in their patterns of contractile and cytoskeletal smooth muscle marker expression (Deugnier et al., 1995) . At least in part, this heterogeneity may reflect transient differences in the degree of maturation of the myoepithelial cells located in the various parts of the mammary tree, or differences in the functional properties of ductal and alveolar myoepithelial cells, such as contractile activity. For instance, it seems plausible that the expression of contractile proteins is upregulated in alveolar myoepithelial cells from lactating glands. Jolicoeur (2005) suggested that the heterogeneity of myoepithelial cells "may reflect an innate ability of the mammary basal myoepithelial lineage to adapt to a wide range of environments", enabling these cells to mediate epithelial-stromal interactions adequately.
Contractile function and the control of mammary myoepithelial cell differentiation
The intrinsic contractile activity of mammary myoepithelial cells is essential for their physiological function. In lactating mammary gland, myoepithelial cell contraction is induced by the pulsatile release of oxytocin from the pituitary gland. Oxytocin binds to a promiscuous G protein-coupled receptor on the surface of the myoepithelial cell (reviewed in Reversi et al., 2005) . As in smooth muscle cells, the contraction of myoepithelial cells is regulated by myosin light chains (MLC). Phosphorylation of the MLC induces myosin ATPase activity, the binding of myosin to actin and contraction (Hartshorne et al., 1989) . The subsequent dephosphorylation of MLC by a specific phosphatase leads to relaxation. We recently showed that, in addition to the phospholipase C/Ca 2+ / MLC pathway (Reversi et al., 2005) , the RhoA/ ROCK signaling cascade is essential for the oxytocin-induced contraction of myoepithelial cells (Raymond et al., 2011) . We found that ROCK inhibition completely prevented the contractile response of myoepithelial cells to oxytocin.
The contractile activity of myoepithelial cells requires the expression of smooth muscle proteins and appropriate cell-ECM interactions. Similar to smooth muscle cells, differentiation of myoepithelial cells is dependent on serum response factor (SRF), a transcription factor that binds a DNA sequence known as the CArG box, associated with smooth muscle structural genes, such as the a-SMA and smooth muscle myosin heavy chain genes. SRF interacts with members of the myocardin family of transcriptional coactivators that enhance the expression of SRF-dependent genes (see references in Pipes et al., 2006) . Myocardin itself is expressed specifically in cardiac and smooth muscle cells, whereas mammary myoepithelial cells express the myocardin-related transcription factors Mkl1 and
Mkl2 (see references in Pipes et al., 2006) . The mammary glands of MKL1-deficient mice develop normally, but mutant dams fail to feed complete litters, due to impairment of the contractile function of the myoepithelial cells. In the absence of MKL1, mammary myoepithelial cells contain only very low amounts of proteins essential for contraction, such as smooth muscle variants of actin, myosin heavy chains, tropomyosin, transgelin, caldesmon and myosin light chain kinase. Mkl2 is upregulated in mutant tissue, but cannot replace MKL1 (Pipes et al., 2006) .
Unlike myocardin, which localizes to the cell nucleus, myocardinrelated proteins are associated with cytoplasmic monomeric G-actin. Rho GTPases positively regulate smooth muscle-specific Srf target gene expression, due to their ability to induce F-actin polymerization, leading to the release of cytoplasmic MKL1. Subsequent nuclear accumulation of MKL1 enables the protein to act as SRF co-activator, promoting smooth muscle differentiation (Pipes et al., 2006) . a-SMA is the most abundant actin isoform in mammary myoepithelial cells. A recent study showed that a-SMA was necessary for the contractile function of myoepithelial cells and for generation of the contractile force required for milk ejection. Mice lacking a-SMA presented lactation failure, despite the normal development of their mammary glands (Haaksma et al., 2011) . Experiments in vitro revealed that the contractile response to oxytocin of myoepithelial cells lacking a-SMA was impaired. Expression of other contractile proteins was not analyzed in this study, but the authors suggested that the lack of a-SMA might alter actin dynamics, leading to G-actin accumulation, thereby decreasing the transcriptional activity of MKL1 and the expression of other smooth muscle contractile proteins.
Another known regulator of smooth muscle-specific protein expression is TGF-b. A transcriptional regulator activated by TGF-b, SMAD3, interacts with MKLs, thereby controlling smooth muscle lineage differentiation (reviewed in Pipes et al., 2006) . In addition to their role in the regulation of smooth muscle-specific SRF targets, MKL1 and SMAD3 participate in control of the expression of Slug (Morita et al., 2007) , a transcription factor essential for the epithelium-to-mesenchyme transition. In mammary epithelium, Slug has been implicated in control of the basal cell phenotype. This protein is found only in the basal myoepithelial cell layer (Mani et al., 2008; Proia et al., 2010) .
The Notch pathway has been reported to contribute to the control of the smooth muscle phenotype (Morrow et al., 2008) and implicated in the amplification of mammary myoepithelial progenitors (Dontu et al., 2004) . The impact of Notch signaling on control of the balance of smooth muscle (and, probably, myoepithelial) cell proliferation and differentiation is context dependent. On the one hand, Notch signaling directly activates the transcription of smooth muscle-specific genes, whereas, on the other hand, its downstream targets, acting in concert with other signaling pathways, can inhibit the expression of smooth muscle markers inducing dedifferentiation (Morrow et al., 2008) . A recent report has suggested a role for the EGFR-ERK1/2 signaling pathway in the control of the propagation of the mammary basal cell population (Pasic et al., 2011) . However, the effects of EGFR ligands on the expression of smooth musclespecific proteins has not been examined in this study.
Myoepithelial cell-ECM interactions
Cell-ECM interactions play important roles in the control of various aspects of the mammary epithelial cell functional activity.
The mammary epithelium is surrounded by a basement membrane consisting essentially of collagen IV, various laminin variants and nidogen (reviewed in Muschler and Streuli 2010). Due to their direct contact with the basement membrane, myoepithelial cells are particularly rich in integrins. Early immunohistochemical studies have revealed the expression of various integrin dimers, including collagen receptors a1b1, a2b1 and fibronectin receptor a5b1, a v b3 integrin and high levels of laminin receptors a3b1, a6b1 and a6b4, in rodent and human mammary myoepithelial cells (see references in Taddei et al., 2003 and in Muschler and Streuli 2010) .
Mice lacking the a1 or a2 integrin chain are viable. The germline deletion of the a1 integrin gene has no effect on mammary development, whereas ablation of the a2 integrin gene results in a slight decrease in mammary ductal branching complexity in virgin mice (reviewed in Hynes 2002). A lack of a3b1 or a6b4 integrins leads to perinatal lethality (reviewed in Hynes 2002). Therefore, tissue transplantation technique has been employed to study the roles played by these integrins in mammary development. Mammary epithelium deficient for a3 or a6 integrin chain (i.e. depleted of a3b1 or a6b1 and a6b4 integrin dimers), when transplanted into cleared mouse mammary fat pads, produced ducts and alveoli similar to those developed from control tissue, suggesting that these integrins are dispensable for mammary morphogenesis. One possible explanation for these results is the functional redundancy of the a3b1, a6b1 and a6b4 integrins.
To study the roles played by integrins expressed in the mammary myoepithelial cells in mammary gland development, we employed conditional gene deletion involving Cre-Lox approach. We have obtained mouse mutants presenting deletion of b1 or a3 integrin chains in the basal (K5-positive) cell population. The expression of Cre was driven to basal epithelial cells by the K5 promoter (Taddei et al., 2008; Raymond et al., 2011) .
The deletion of b1 integrin from basal myoepithelial cells affected mammary branching morphogenesis in virgin mice and lobulo-alveolar development in pregnancy (Taddei et al., 2008) . The mutant epithelium was characterized by a largely disorganized general branching pattern, with few side branches. Lobulo-alveolar development was significantly retarded and secretory alveoli developed only late in pregnancy, after 14.5 p.c. from integrin-positive progenitor cells residing in the luminal layer. However, the deletion of b1 integrins from the basal myoepithelial cell compartment did not impede ductal growth or differentiation of the two major mammary lineages, the basal myoepithelial and the luminal.
Furthermore, in the mutant epithelium, the lack of b1 integrin altered the orientation of the basal cell division axis and the progeny of b1 integrin-depleted basal cells, identified by a genetic marker, was found in the luminal compartment, by contrast to what was observed for control tissue. These observations led to the conclusion that, in the developed ducts, basal mammary epithelial cells divided parallel to the basement membrane, whereas basal cells lacking b1 integrin escaped this rule. In this case, orientation of the basal cell division plane appeared to be random, so that part of the progeny localized to the luminal compartment and differentiated into luminal cells. These data suggested, that interactions between basal cells and ECM may contribute to cell fate decisions in mammary epithelium.
Serial transplantation experiments revealed that the deletion of b1 integrin from the basal myoepithelial cell layer abolished the regenerative potential of the mammary epithelium. It is not known how cell-ECM interactions mediated by b1 integrins contribute to maintenance of the mammary stem cell population, and whether the deletion of b1 integrin affects stem cells, directly, or indirectly, by modifying their survival or self-renewal capacity or disturbing the stem cell niche. Numerous studies have shown that cell-ECM adhesion plays an essential role in various stem cell niches (Raymond et al., 2009) .
The conditional deletion of a laminin receptor, a3b1 integrin, from myoepithelial cells did not interfere with the integrity or functional differentiation of the mammary epithelium, but led to low rates of milk ejection due to impaired myoepithelial cell contractility (Raymond et al., 2011) . This study revealed that in mammary myoepithelial cells, a3b1 integrin-mediated interactions with the ECM play an essential role in the control of FAK-Rac-PAK pathway activation thereby participating in the regulation of the myoepithelial cell post-contraction relaxation. In the mammary glands of lactating mice presenting deletion of a3b1 integrin from basal myoepithelial cells, we observed sustained MLC phosphorylation, low levels of FAK activation/phosphorylation and altered Rho/ Rac balance. Cultured mammary myoepithelial cells depleted of a3b1 contracted in response to oxytocin, but were unable to maintain the state of post-contractile relaxation. The expression of constitutively active Rac or its effector PAK, or treatment with MLC-kinase inhibitor rescued the relaxation capacity of mutant cells, strongly suggesting that a3b1-mediated stimulation of the Rac/PAK pathway is required for the inhibition of MLC-kinase activity, permitting completion of the myoepithelial cell contraction/ relaxation cycle and successful lactation. This study provided the first in vivo evidence implicating integrin signaling in the control of myoepithelial cell contractile function.
Intercellular and paracrine interactions involving myoepithelial cells
Like other epithelial cells, mammary basal myoepithelial cells form junctional complexes, including desmosomes and adherens junctions, between them and with luminal cells. Of note, numerous cell-cell-adhesion molecules are expressed differentiatially in basal and luminal cells of the mammary epithelium. Many cell-celladhesion molecules display differential expression between the basal and luminal cells of the mammary epithelium. Runswick and coworkers provided evidence that desmosomes play an important role in the establishment and maintenance of the bilayer organization (Runswick et al., 2001) . Desmosomal cadherins, desmocolin 3 and desmoglein 3 are restricted to the myoepithelium. Perturbation of the cell-cell interactions involving these myoepithelium-specific molecules interfere with the cell type-specific positioning of luminal and basal mammary epithelial cells.
Cadherins are adherens junction components essential for the maintenance of epithelial tissue architecture. P-cadherin is expressed in the basal cell layers of stratified and pseudostratified epithelia. In mammary gland, P-cadherin is restricted to the basal cell layer, including ductal and alveolar myoepithelial cells and cap cells from terminal end buds. P-cadherin-deficient mice present unscheduled lobulo-alveolar development (Radice et al., 1997) . Alveolus-like structures, similar to those seen early in pregnancy, develop in mutant virgin females, and luminal cells present signs of lactogenic differentiation. Late in life, P-cadherin-deficient mice develop hyperplastic and dysplastic lesions (Radice et al., 1997) .
This study suggested that the deletion of P-cadherin, an adhesion molecule expressed by basal cells, affected the luminal cell population. Further studies are required to determine how basal cells contribute to the control of luminal cell proliferation and differentiation.
The molecular mechanisms that control P-cadherin expression remain poorly understood. Using mammary epithelial cell lines and mouse mutants obtained in our laboratory, we have shown that the Wnt/b-catenin signaling pathway is involved in regulation of P-cadherin expression independently of the Lef/Tcf transcription factors (Faraldo et al., 2007) . High levels of P-cadherin were found in mammary glands from transgenic mice presenting a constitutive activation of b-catenin signaling in basal myoepithelial cells (Faraldo et al., 2007) .
Novel information about the nature of cell-cell interactions in the mammary epithelium has been provided by Hinck's laboratory. This team was the first to implicate neural guidance molecules in basal-luminal cell adhesion and crosstalk. In the mammary epithelium, Netrin1, a secreted guidance cue molecule is expressed by luminal cells, whereas, its receptor, Neurogenin is present on the surface of cap and differentiated myoepithelial cells. Loss-offunction mutations in genes coding for Netrin1 and Neurogenin resulted in the disorganization of terminal end buds (Srinivasan et al., 2003) . Another neural guidance molecules Slit2 is expressed in both mammary epithelial cell layers, whereas its receptor, Robo1 is restricted to the basal cell population, cap and myoepithelial cells. Deletion of Slit2 or Robo1 from the mammary epithelium results in a phenotype similar to that induced by perturbation of Netrin1/ Neurogenin couple, a lack of adhesion between luminal and cap cell layers (Strickland et al., 2006) . Furthermore, simultaneous loss-of-function mutations of slit2 and ntn1 genes resulted in an enhanced phenotype with separated luminal and basal cell layers in the mammary ducts suggestive of synergy between Slit2 and Netrin 1 during ductal morphogenesis. A recent report from the same laboratory implicated Slit/Robo1 signaling in the control of mammary branching morphogenesis (Macias et al., 2011) . The authors suggested that basal myoepithelial cells control the formation of new ductal branches via the production of mitogens for the luminal cells. Macias and coworkers revealed that the TGF-b1-induced expression of Robo1 in basal myoepithelial cells and the interaction of Slit2 with Robo1 inhibited b-catenin signaling, limiting basal cell proliferation and preventing the formation of new branches (Macias et al., 2011) .
Other examples of differential ligand-receptor distribution between basal and luminal cell layers include the Ephrin and Notch signaling pathways. Several studies have confirmed the functional significance of this expression pattern for mammary development. The ephrin receptor, EphB4, is strongly expressed in myoepithelial cells, whereas its ligand, Ephrin 2, is restricted to luminal cells. The ectopic expression of EphB4 in the luminal compartment disrupts proliferation and survival control in the mammary epithelium (Andres and Ziemiecki 2003). The Notch pathway is preferentially active in the luminal cell compartment of the mammary epithelium, and expression of the Notch targets, Hey1 and Hey2 is characteristic of luminal progenitors (Bouras et al., 2008) . By contrast, the Notch ligands Jag1 and 2 and Dlt1 are expressed in mammary basal cells. Thus, direct interactions between basal and adjacent luminal cells may contribute to the control of the expansion of the luminal progenitor population (Bouras et al., 2008) .
In turn, luminal cells also affect the homeostasis of the basal cell population. Wnt signaling is essential for proliferation and functional activity of mammary stem cells localized in the basal compartment (reviewed in Incassati et al., 2010) . Whilst genes coding for several Wnt ligands (Wnt4, Wnt5a, Wnt7b) were found to be expressed by luminal cells, expression of the receptors and co-receptors associated with Wnt/b-catenin signaling (Frizzled 1, 2, 3, 7 , and 8, Lrp5 and 6) was localized to the basal myoepithelial cell compartment suggesting paracrine interactions (Kendrick et al., 2008) .
In quiescent mammary gland of virgin mice, myoepithelial cells do not proliferate. By contrast, stimulation with ovarian hormones, either under experimental conditions (hormone injection), or physiologically (during pregnancy or estrus), induces amplification of the basal myoepithelial cell population and expansion of the mammary stem cell population via paracrine mechanisms involving the Wnt and RANK pathways (Brisken and O'Malley 2010; Incassati et al., 2010; Asselin-Labat et al., 2010; Joshi et al., 2010) . Wnt4 is induced upon stimulation of the mammary epithelium by progesterone (see references in Brisken and O'Malley 2010). Most hormonal receptors are expressed by luminal cells and basal myoepithelial cells do not express ERa at all, but Wnt/b-catenin pathway-associated genes, including targets and receptors, were found to be upregulated in the mammary basal cell population of animals stimulated by estrogen/progesterone injection (Joshi et al., 2010) . Moreover, ovarian hormones induced the expression of RANKL in luminal cells and the expression of its receptor, RANK, in luminal and, particularly, basal cells Joshi et al., 2010) .
Large-scale microarray analysis of gene expression patterns in various mammary epithelial cell populations performed with freshly isolated cells from virgin mouse and human mammary glands revealed numerous genes differentially expressed in basal and luminal cells Kendrick et al., 2008; Lim et al., 2010) . These studies provided important information for future work aiming to unravel the molecular mechanisms underlying crosstalk between the two major compartments of the mammary epithelium, the basal and luminal compartments. The microarray data complemented functional studies and indicated signaling pathways potentially involved in basal-luminal paracrine or direct cell-cell interactions and revealed several transcription regulators characterized by a cell type-specific expression pattern.
Mammary myoepithelium and stem cells
Studies performed with a mammary cell line CommaD1b, possessing a morphogenetic potential, and with dissociated mammary epithelial cells have strongly suggested that the regenerative capacity of the mammary epithelium, as evaluated by transplantation assays, is associated with the basal epithelial compartment (Deugnier et al., 2006; Shackleton et al., 2006; Stingl et al., 2006; Sleeman et al., 2007) . Cell populations enriched in stem cells can be isolated from freshly dissociated mammary epithelium, by flow cytometry, due to the strong expression of a6 or b1 integrins Stingl et al., 2006) . Of note, relatively high integrin expression levels are characteristic of the entire basal mammary cell population, consisting essentially of differentiated myoepithelial cells, whereas stem cells would be expected to display phenotypic characteristics different from those of differentiated cells. Consistently, the morphogenetic cell population isolated from the CommaD1b cell line expresses basal cell markers, such as basal cytokeratins, P-cadherin and DNp63, but is negative for the smooth muscle-characteristic proteins (Deugnier et al., 2006) .
Putative mammary stem cells have not yet been physically separated from the differentiated myoepithelial cells, the major cell population in the mammary basal compartment. Stingl and coworkers have reported that repopulating activity is associated with a small cell fraction with higher levels of a6 integrin than the rest of the basal myoepithelial cell population. However, a comparative transcriptome analysis revealed that there were no significant differences in gene expression between these two basal cell subsets . Smooth muscle-specific contractile and cytoskeletal proteins were present in similar amounts in both cell populations. The myoepithelial cell layer is heterogeneous, but undifferentiated cells negative for smooth muscle markers have not yet been clearly identified in vivo, in rodent or human mammary basal epithelial cell layer.
Consistent with the transplantation data, lineage tracing experiments with the mouse reporter strain Rosa 26 led to the conclusion that all mammary epithelium cells originated from stem/ progenitor cells expressing the basal cytokeratins K5/K14 (Choi et al., 2009; Moumen and Faraldo, unpublished data) . However, there is no experimental evidence to confirm that multipotent stem cells localized in the mammary basal cell layer contribute to the luminal compartment during ductal growth at puberty and lobuloalveolar development in pregnancy. The results of lineage tracing experiments are consistent with the hypothesis that multipotent stem cells with basal characteristics (K5/K14-positive) give rise to basal myoepithelial and luminal cell lineages during early stages of mammary gland development, and that once the system of branching ducts is formed, the basal cell population makes no further contribution to the luminal cell layer.
Thus, it is still unclear whether an undifferentiated stem cell population exists in pubertal and adult mammary glands. It also remains to be determined whether cells possessing the regenerating potential revealed in transplantation assays, are phenotypically different from the surrounding differentiated myoepithelial cells, or whether at least some of the myoepithelial cells can dedifferentiate and acquire stem cell properties after transplantation.
Although differentiated myoepithelial cells from adult animals may be devoid of stem cell activity, they seem very likely to contribute to the mammary stem cell niche, by producing the necessary growth factors or ECM components. A recent analysis of gene expression patterns in basal and luminal cell populations isolated from human and mouse mammary epithelium confirmed that basal cells expressed numerous ECM proteins in large amounts, including most of the mammary basement membrane constituents, such as laminins, collagens, fibronectin, heparan sulphate proteoglycans and SPARC (Kendrick et al., 2008; Lim et al., 2010) .
Contribution of myoepithelial cells to mammary tumorigenesis
Mammary myoepitheliomas are rare malignant tumors considered to originate from myoepithelial cells. These tumors are characterized by high-level expression of basal epithelial cell markers and, in some cases, the expression of smooth muscle-specific proteins (Buza et al., 2010 and references therein) .
Large-scale analyses of gene expression in human breast carcinomas led to the discovery of a tumor subset characterized by the expression of basal epithelial cell markers, the absence of ER-and PR-positive cells and the lack of HER2 overexpression. These tumors are usually referred to as basal-type or triple negative (reviewed in Gusterson 2009; Foulkes et al., 2011) . These tumors were initially thought to originate from mammary progenitor/stem cells. However, several recent studies have provided evidence that, at least, partially contradicted this hypothesis. Hereditary mammary carcinomas associated with the brca1 gene mutation belong to the basal subtype. It has been demonstrated that luminal progenitors are amplified in the mammary epithelium of brca1-mutation carriers suggesting that this cell population might be at the origin of basal-type BRCA1-mammary carcinomas (Lim et al., 2009) . Interestingly, the basal cell population was notably decreased in the mammary epithelium of these individuals (Lim et al., 2009) .
Further, experiments employing a mouse model of breast carcinogenesis demonstrated that deletion of the brca1 gene from the luminal layer of the mammary epithelium of mice heterozygous for p53 was led to the development of tumors phenotypically similar to human BRCA1-associated carcinomas (Molyneux et al., 2010) . The deletion of brca1 from the basal myoepithelial cell layer led to the development of adenomyoepitheliomas and squamous metaplastic carcinomas. Although the tumors developed after the disruption of brca1 gene expression in the basal cell layer were of the basal subtype, based on their transcriptional profiles, their histological characteristics differed from human BRCA1 tumors (Molyneux et al., 2010) . Finally, a study from the Kuperwasser laboratory revealed that the transcriptional repressor Slug accumulated in BRCA1-associated breast cancer may be responsible for the basal phenotypic characteristics of the tumor cells (Proia et al., 2010) . The Wnt/b-catenin signaling pathway is activated in basal-type mammary carcinomas (Khramtsov et al., 2010) . We investigated the role of this pathway in mammary gland development and tumorigenesis, by generating transgenic mice expressing in the basal epithelial cell layer, an "activated" (N-terminally truncated and, thus, stabilized) b-catenin under control of the K5-promoter (transgenic lines K5-DNbcat). K5-DNbcat mice have an abnormal mammary phenotype, including precocious side branching in pregnancy, associated with an increase in proliferation and a decrease in the apoptosis of luminal epithelial cells and accelerated post-lactational involution (Faraldo et al., 2005) . By the age of 12 to 16 months, 75% of K5-DNbcat nulliparous females develop mammary hyperplasia comprising K5-positive (basal) cells negative for luminal and myoepithelial cell markers. Most multiparous K5-DNbcat mice develop invasive mammary carcinomas consisting essentially of undifferentiated basal epithelial cells or presenting signs of differentiation towards epidermal lineages (Faraldo et al., 2005) . We suggest that the activation of b-catenin signaling in mammary basal epithelial cell induces the amplification of basaltype progenitors, and, that basal-type progenitor/stem cells may contribute to the development of a subset of basal-type mammary carcinomas, metaplastic lesions characterized by the expression of epidermal lineage markers.
Conclusions and perspectives
Myoepithelial cells are no longer considered to be a secondclass mammary cell population of almost no interest. In addition to its contractile function, which is essential for lactation, the basal cell layer harbors the regenerative potential of the mammary epithelium. Basal myoepithelial cells modulate the proliferation and differentiation of luminal cells, and affect the surrounding stroma. Various aspects of myoepithelial cell biology therefore merit further investigation.
Recent studies have shed light on the nature of the reciprocal paracrine and adhesion-mediated regulatory signals between the basal and luminal compartments of the mammary epithelium. However, our knowledge of these complex interactions is still limited, and detailed descriptions and analysis of the basal-luminal cell crosstalk are required to define the roles played by the myoepithelial cells in normal development and tumorigenesis. Several of the studies discussed above suggested that triple-negative breast tumors might originate from luminal progenitors (Lim et al., 2009; Molyneux et al., 2010; Proia et al., 2010) . However, some of the signals essential for the maintenance of this cell population are thought to be provided by basal cells (Bouras et al., 2008) implying that the question of the contribution of the mammary basal cell compartment to tumorigenesis is still open.
A particularly important subject for further studies is to define the effects of the myoepithelium on the stroma during development and in disease. One aspect of the myoepithelium-stroma crosstalk yet to be unraveled is the contribution of the mammary myoepithelial cells to the establishment of the vascular network in the connective tissue surrounding the epithelium. As discussed elsewhere (Barsky and Karlin 2006), myoepithelial cells are considered to exhibit the anti-angiogenetic properties, however, they express VEGFa, and its deletion from the basal cell layer significantly attenuated the angiogenesis accompanying mammary development (Rossiter et al., 2007) .
Another intriguing issue is the relationships between myoepithelial and stem/progenitor cells. It is not known yet whether upon transplantation, rare undifferentiated cells possessing stem cell properties give rise to mammary epithelial outgrowths, or, alternatively, all or a subset of myoepithelial cells can dedifferentiate and acquire the repopulating potential. We therefore believe that the phenotypic heterogeneity of the basal myoepithelial cell population in quiescent and hormone-stimulated glands, and control of the smooth muscle differentiation program in the myoepithelium merit further investigation.
